1. dwright29
2. servigener
4. lucaptr
5. golemelin
1.dwright29 02/12/2018
BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients with Urothelial Carcinoma at 2018 Genitourinary Cancers Symposium
2.servigener 01/31/2018
More DD
3.golemelin 02/09/2018
Presents preliminary Phase 1 data on Tislelizumab in patients with Urothelial Carcinoma
4.dwright29 02/05/2018
Announced the commercial availability of VIDAZA (azacitidine for injection) in China
5.golemelin 01/31/2018
Great pipeline with this bio
6.waseem0pola 04/11/2018
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma
7.MAJDAVARAN 09/27/2017
Bios are doing a lot better lately
8.servigener 04/10/2018
Announced that the first patient was dosed in a global Phase 2 clinical trial of tislelizumab, an investigat…
9.servigener 01/31/2018
Good hopes with $BGNE
10.MAJDAVARAN 01/18/2018
Market really liked this>?!
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW